Chronic antipsychotic treatment: Protracted decreases in phospho-TrkA levels in the rat hippocampus

Alvin V. Terry, Debra A. Gearhart, Anilkumar Pillai, Guodong Zhang, Michael G. Bartlett

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

There is growing evidence of neurotrophin alterations in neuropsychiatric illnesses such as schizophrenia and further, neurotransmitters known to be adversely affected in schizophrenia (e.g. dopamine) can activate neurotrophin signalling pathways via G protein-coupled receptors. However, it is unclear how the primary therapeutic agents used in schizophrenia affect neurotrophin signalling. This is important given that all currently prescribed antipsychotic drugs serve as ligands at dopamine receptors. In this study, chronic effects of representative conventional and second-generation antipsychotics on nerve growth factor (NGF) receptor levels were assessed in the rat. The results indicated no significant drug effects on TrkA levels in any brain region analysed; however, three of the five antipsychotics analysed significantly decreased phospho-TrkA (i.e. the activated form of the receptor) in the hippocampus. These data indicate that chronic antipsychotic treatment may result in deleterious effects on neurotrophin signalling in an important brain region for information processing and cognition.

Original languageEnglish (US)
Pages (from-to)799-805
Number of pages7
JournalInternational Journal of Neuropsychopharmacology
Volume13
Issue number6
DOIs
StatePublished - Jul 1 2010

Fingerprint

Nerve Growth Factors
Antipsychotic Agents
Hippocampus
Schizophrenia
Nerve Growth Factor Receptor
Dopamine Receptors
Brain
G-Protein-Coupled Receptors
Automatic Data Processing
Cognition
Neurotransmitter Agents
Dopamine
Ligands
Pharmaceutical Preparations
Therapeutics

Keywords

  • TrkA
  • cognition
  • nerve growth factor
  • neurotrophin
  • schizophrenia

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Chronic antipsychotic treatment : Protracted decreases in phospho-TrkA levels in the rat hippocampus. / Terry, Alvin V.; Gearhart, Debra A.; Pillai, Anilkumar; Zhang, Guodong; Bartlett, Michael G.

In: International Journal of Neuropsychopharmacology, Vol. 13, No. 6, 01.07.2010, p. 799-805.

Research output: Contribution to journalArticle

@article{538f57275e9f4cedb07e783689fdb85b,
title = "Chronic antipsychotic treatment: Protracted decreases in phospho-TrkA levels in the rat hippocampus",
abstract = "There is growing evidence of neurotrophin alterations in neuropsychiatric illnesses such as schizophrenia and further, neurotransmitters known to be adversely affected in schizophrenia (e.g. dopamine) can activate neurotrophin signalling pathways via G protein-coupled receptors. However, it is unclear how the primary therapeutic agents used in schizophrenia affect neurotrophin signalling. This is important given that all currently prescribed antipsychotic drugs serve as ligands at dopamine receptors. In this study, chronic effects of representative conventional and second-generation antipsychotics on nerve growth factor (NGF) receptor levels were assessed in the rat. The results indicated no significant drug effects on TrkA levels in any brain region analysed; however, three of the five antipsychotics analysed significantly decreased phospho-TrkA (i.e. the activated form of the receptor) in the hippocampus. These data indicate that chronic antipsychotic treatment may result in deleterious effects on neurotrophin signalling in an important brain region for information processing and cognition.",
keywords = "TrkA, cognition, nerve growth factor, neurotrophin, schizophrenia",
author = "Terry, {Alvin V.} and Gearhart, {Debra A.} and Anilkumar Pillai and Guodong Zhang and Bartlett, {Michael G.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1017/S1461145709991040",
language = "English (US)",
volume = "13",
pages = "799--805",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - Chronic antipsychotic treatment

T2 - Protracted decreases in phospho-TrkA levels in the rat hippocampus

AU - Terry, Alvin V.

AU - Gearhart, Debra A.

AU - Pillai, Anilkumar

AU - Zhang, Guodong

AU - Bartlett, Michael G.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - There is growing evidence of neurotrophin alterations in neuropsychiatric illnesses such as schizophrenia and further, neurotransmitters known to be adversely affected in schizophrenia (e.g. dopamine) can activate neurotrophin signalling pathways via G protein-coupled receptors. However, it is unclear how the primary therapeutic agents used in schizophrenia affect neurotrophin signalling. This is important given that all currently prescribed antipsychotic drugs serve as ligands at dopamine receptors. In this study, chronic effects of representative conventional and second-generation antipsychotics on nerve growth factor (NGF) receptor levels were assessed in the rat. The results indicated no significant drug effects on TrkA levels in any brain region analysed; however, three of the five antipsychotics analysed significantly decreased phospho-TrkA (i.e. the activated form of the receptor) in the hippocampus. These data indicate that chronic antipsychotic treatment may result in deleterious effects on neurotrophin signalling in an important brain region for information processing and cognition.

AB - There is growing evidence of neurotrophin alterations in neuropsychiatric illnesses such as schizophrenia and further, neurotransmitters known to be adversely affected in schizophrenia (e.g. dopamine) can activate neurotrophin signalling pathways via G protein-coupled receptors. However, it is unclear how the primary therapeutic agents used in schizophrenia affect neurotrophin signalling. This is important given that all currently prescribed antipsychotic drugs serve as ligands at dopamine receptors. In this study, chronic effects of representative conventional and second-generation antipsychotics on nerve growth factor (NGF) receptor levels were assessed in the rat. The results indicated no significant drug effects on TrkA levels in any brain region analysed; however, three of the five antipsychotics analysed significantly decreased phospho-TrkA (i.e. the activated form of the receptor) in the hippocampus. These data indicate that chronic antipsychotic treatment may result in deleterious effects on neurotrophin signalling in an important brain region for information processing and cognition.

KW - TrkA

KW - cognition

KW - nerve growth factor

KW - neurotrophin

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=77957158997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957158997&partnerID=8YFLogxK

U2 - 10.1017/S1461145709991040

DO - 10.1017/S1461145709991040

M3 - Article

C2 - 20059802

AN - SCOPUS:77957158997

VL - 13

SP - 799

EP - 805

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 6

ER -